Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Immune Senescence”

Showing 20 of 0 results

Not applicableStudy completedNCT01920464
What this trial is testing

Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 160
Large-scale testing (Phase 3)Study completedNCT00192257
What this trial is testing

Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma

Who this might be right for
Asthma
MedImmune LLC 2,229
Testing effectiveness (Phase 2)Ended earlyNCT01313611
What this trial is testing

BRIEF Bendamustine and Rituximab In Elderly Follicular

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 62
Not applicableUnknownNCT04313699
What this trial is testing

Geriatric HIV Cohort in Sub Sahara Africa

Who this might be right for
HIV InfectionsNon Communicable DiseasesAging
Makerere University 500
Large-scale testing (Phase 3)Study completedNCT01144364
What this trial is testing

MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 234
Not applicableStudy completedNCT00823589
What this trial is testing

Immune Status of Elderly Population Admitted in an Acute Geriatric Unit

Who this might be right for
Aging
Assistance Publique Hopitaux De Marseille 78
Testing effectiveness (Phase 2)Study completedNCT02533180
What this trial is testing

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

Who this might be right for
Liver TransplantLiver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00834951
What this trial is testing

Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Non Hodgkin's Lymphoma
University of Aarhus 40
Large-scale testing (Phase 3)Study completedNCT00109486
What this trial is testing

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Who this might be right for
Rhinitis, Allergic, Perennial and Seasonal
GlaxoSmithKline 56
Large-scale testing (Phase 3)Study completedNCT00993473
What this trial is testing

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 125
Testing effectiveness (Phase 2)Looking for participantsNCT07297602
What this trial is testing

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Who this might be right for
Atopic Dermatitis
Nora Mohamed Abdelrazik 36
Early research (Phase 1)Study completedNCT06702462
What this trial is testing

Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Who this might be right for
Asthma
GlaxoSmithKline 20
Not applicableStudy completedNCT03051425
What this trial is testing

Immune Benefits of Consumption of Dairy Yogurt in Elderly

Who this might be right for
Immune Deficiency
Yonsei University 200
Early research (Phase 1)Study completedNCT00814762
What this trial is testing

Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old

Who this might be right for
AIDS
GlaxoSmithKline 41
Testing effectiveness (Phase 2)Study completedNCT01274403
What this trial is testing

Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gruppo Italiano Studio Linfomi 130
Not applicableUnknownNCT03509259
What this trial is testing

Cardiovascular Diseases in Elderly Asthma

Who this might be right for
Asthma
Seoul National University Hospital 72
Not applicableStudy completedNCT07530861
What this trial is testing

Nutritional and Anthropometric Characteristics of Children With Food Allergy

Who this might be right for
Food Allergy in Children
Necmettin Erbakan University 185
Early research (Phase 1)Study completedNCT04765449
What this trial is testing

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

Who this might be right for
Covid19
Thomas Jefferson University 30
Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Not applicableLooking for participantsNCT06338072
What this trial is testing

Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1).

Who this might be right for
Type 1 Diabetes
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 119
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation